ALBT (Avalon GloboCare Corporation) סך נכסים נקיים

Avalon GloboCare (ALBT) provides cellular diagnostics and laboratory research services. The company's price chart visualizes scaling potential via a cloud-based AI service that processes genetics without increasing headcount, with the metric standing at -0.03. Standard tests currently generate revenue, while medium-term growth is expected from oncology therapies. Business success relies on digital health monitoring and a strategic alliance with medical centers.

For a fundamental valuation of Avalon GloboCare (ALBT), analyzing equity dynamics is critical, as it reflects the real value of net assets minus liabilities. The company's total book capitalization allows for the tracking of daily liquidity and the funding stability of healthcare ESG initiatives, confirming the issuer's ability to invest in energy-efficient IT platforms without the risk of debt overload or capital drawdown.